Overview

  • Product nameAmyloid β Peptide (31-35)
  • Description
    Amyloidogenic peptide. Amyloid β Peptide (31-35).
  • Biological description

    Amyloidogenic peptide. Induces apoptosis/neurodegeneration in vitro. These effects are orchestrated by the oxidation status of methionine 35. Involves a number of signaling pathways including JNK, caspases and PKA.

  • Purity> 95%

Properties

    References for Amyloid β Peptide (31-35) (ab120974)

    This product has been referenced in:
    • Zhao L  et al. Amyloid beta-peptide 31-35-induced neuronal apoptosis is mediated by caspase-dependent pathways via cAMP-dependent protein kinase A activation. Aging Cell 7:47-57 (2008). Read more (PubMed: 18005252) »
    • Misiti F  et al. Methionine 35 oxidation reduces toxic and pro-apoptotic effects of the amyloid beta-protein fragment (31-35) on isolated brain mitochondria. Neuroscience 126:297-303 (2004). Read more (PubMed: 15207347) »
    • Yan XZ  et al. Beta-amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons. Neuroscience 92:177-84 (1999). Read more (PubMed: 10392840) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120974.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"